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Background: Obesity is associated with a higher risk of developing cancer and co-morbidities that are part of the
metabolic syndrome. Adipose tissue is recognized as an endocrine organ, as it affects a number of physiological
functions, and contains adipose tissue-derived stem cells (ASCs). ASCs can differentiate into cells of multiple
lineages, and as such are applicable to tissue engineering and regenerative medicine. Yet the question of whether
ASC functionality is affected by the donor’s body mass index (BMI) still exists.
Results: ASCs were isolated from patients having different BMIs (BMI-ASCs), within the ranges of 18.5-32.8. It was
hypothesized that overweight BMI-ASCs would be more compromised in early adipogenic and osteogenic
potential, and ability to form colonies in vitro. BMI was inversely correlated with ASC proliferation and colony
forming potential as assessed by CyQUANT proliferation assay (fluorescence- based measurement of cellular DNA
content), and colony forming assays. BMI was positively correlated with early time point (day 7) but not later time
point (day 15) intracytoplasmic lipid accumulation as assessed by Oil-Red-O staining. Alizarin red staining and
RT-PCR for alkaline phosphatase demonstrated that elevated BMI resulted in compromised ASC mineralization of
extracellular matrix and decreased alkaline phosphatase mRNA expression.
Conclusions: These data demonstrate that elevated BMI resulted in reduced ASC proliferation, and potentially
compromised osteogenic capacity in vitro; thus BMI is an important criterion to consider in selecting ASC donors
for clinical applications.
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Cell sizeBackground
The increasing epidemic of obesity within the United
States has been associated with a higher risk of develop-
ing co-morbidities that are categorized as part of the
metabolic syndrome that include dyslipoproteinemia
(raised triglyceride and/or reduced high density lipopro-
tein cholesterol levels), diabetes mellitus, and cardiovas-
cular and coronary artery diseases. Obesity has also been
identified as a risk factor for an increased incidence of
several forms of cancer, including colon and breast can-
cers [1-5]. A high incidence of these morbidities exists
in obese individuals, both adolescents and adults [3,4,6].* Correspondence: browan@tulane.edu
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reproduction in any medium, provided the orRecent studies have also investigated the effects of obesity
on the musculoskeletal system [7], and have identified
obesity as an independent risk factor for increased bone
fracture risk [8] and clinical implant failure following total
joint replacement [9-14]. Obese individuals with higher
body mass indices (BMIs; the ratio of body weight (kg) to
height (m2)) exhibit lower relative bone area and bone
mass compared to non-obese individuals [15]. While vari-
ous explanations have been widely suggested, our know-
ledge relating the pathogenesis of obesity at the cellular
level and its potential impact in tissue engineering and re-
generative medicine applications is very limited.
Adipose tissue is a complex, highly active endocrine
organ that secretes bioactive peptides, or adipocytokines,
that are known to affect a number of physiological func-
tions in the reproductive system, neuroendocrine system,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 BMI-ASCs used in the study
Lot number Age Body mass index






Mean ± SD 42.3 ± 5.46 22.2 ± 1.79






Mean ± SD 42.3 ± 5.46 22.2 ± 1.79
All donors Mean ± SD 42.3 ± 5.46 22.2 ± 1.79
All ASCs were obtained from subcutaneous abdominal adipose tissue of
female, Caucasian donors of ages between 28 and 61 with a mean ± SD of
41.5 ± 8.61 years. ASCs isolated from patients having different body mass
indices (BMIs) were designated BMI-ASCs. BMI-ASCs used in the study were
grouped into categories and identified as either ‘lean BMI-ASCs’ (BMI <25) or
‘overweight BMI-ASCs’ (>30). The patients displayed a mean body mass index
(kg/m2) (±SD) of 26.3 ± 4.62.
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[16-18]. Adipose tissue contains mature adipocytes,
endothelial cells, cells of the immune system, and a
small percentage of the adipocyte precursors termed
adipose tissue-derived stem cells (ASCs). The ability
of ASCs to differentiate into cells of the endodermal,
mesodermal, and ectodermal lineages makes ASCs optimal
candidates for applications in cellular therapies [19], includ-
ing tissue engineering and regenerative medicine [20-23].
These applications potentially involve the repair of the
musculoskeletal and other biological systems [24,25]. How-
ever, the growing interest in ASCs for cell therapeutics has
led to questions about donor physiological conditions on
ASC functionality (i.e. effects on viability, differentiation,
and growth properties).
Recent reports have positively correlated BMI with ASC
yields from adipose tissue and inversely correlated BMI
with adipocyte size [26]. BMI has also been inversely corre-
lated with bone-marrow derived mesenchymal stem cell
(BMSC) cyclic tensile strain capacity, or mechano-response,
and alkaline phosphatase activity in vitro, which suggested
a possible compromise in the osteogenic differentiation po-
tential of BMSCs from individuals with higher BMIs [5].
Similar studies on ASCs have not been conducted.
The current study investigated the proliferation ability,
in vitro differentiation potential, relative cell volume and
complexity, and colony forming potential of ASCs isolated
from patients having different BMIs, within the ranges
of 18.5-24.9 kg/m2, (designated lean BMI-ASCs), and
25–32.8 kg/m2, (designated overweight BMI-ASCs). It
was hypothesized that overweight BMI-ASCs would be
more compromised in the ability to proliferate, differenti-
ate, and form colonies in vitro, thereby contributing to the
problematic obesity-associated pathologies, and therefore
BMI should be considered when using ASCs for regenera-
tive medicine applications.
Results
Percent serum and BMI inversely correlated with ASC growth
Cryopreserved ASCs isolated from lipoaspirates of women
with different body mass indices (BMIs; Table 1), were
cultured for up to 72 hours in ASC culture medium
supplemented with 0 to 10% FBS. Cell growth was
measured by MTT and CyQUANT cell proliferation
assays. Growth data reflected an inverse relationship
between BMI and ASC growth in vitro (Figure 1a,b).
The largest effect was observed in 2% serum for 48 hrs
(Figure 1a); however, growth was also compromised when
ASCs were cultured 10% serum (Figure 1b). MTT data
also revealed a time-dependent biphasic response in cell
growth in which full recovery and maximum growth
occurred at 72 hrs following a decline in higher BMI-
ASC growth at 24 hrs and 48 hrs (data not shown). Non
linear regression analyses using least fit ordinary squaressupported the strong inverse relationship between both
BMI (determination coefficient, R2 = 0.90; p < 0.05) and
serum (R2 = 0.86; p < 0.05) on ASC growth (Figure 1c-f),
where culture in the lowest percent serum (0%) reflected
the strongest determination coefficient. Quadratic equations
were used for nonlinear regression analyses, curve-fitting
and subsequent R2 values (reported in Figure 1c-f).
BMI negatively correlated with colony-forming unit potential
To further examine differences in BMI-ASC growth,
colony-forming unit (CFU) assays were performed on the
BMI-ASC donors (Table 1). These donors were grouped
as follows: lean (BMI <25; mean BMI 22.2 ± 1.79, N = 5),
and overweight (BMI >30; mean BMI 30.3 ± 2.17, N = 5).
When grouped, the lean BMI-ASCs formed a signifi-
cantly higher percentage of colonies (34.94 ± 1.46) com-
pared to the overweight BMI-ASCs (28.26 ± 1.78); p < 0.05
(Figure 2b). Representative photomicrographs of CFUs
are shown in Figure 2c. Annexin-V/PI staining and
fluorescence-activated cell sorting (FACS) was used to
determine whether the compromised growth in higher
BMI-ASCs was accompanied by elevated apoptosis.
There was no significant difference in apoptosis between
lean and overweight BMI-ASCs at 24 and 48 hrs of cul-
ture with 2% or 10% FBS (data not shown). The per-
cent early apoptotic cells did not exceed 5.49 ± 1.86%,
and the percent late apoptotic cells did not exceed
4.12 ± 0.23% (mean ± SD).
Figure 1 Higher BMI-ASCs exhibited compromised growth when exposed to low serum in vitro. a, b. CyQUANT was performed following ASC
exposure to low serum (0-10% FBS supplementation) culture conditions for 48 hrs. Percentage serum and BMI both significantly affect ASC growth. c-f.
Regression analysis of BMI-ASC growth when exposed to low serum in vitro. Nonlinear regression analysis performed using least squares ordinary fit. R2 values
indicate a strong correlation between BMI, percent serum exposure, and ASC growth. Values are reported as N± SE; * p > 0.05, ** p > 0.001, *** p > 0.0001.
Figure 2 BMI negatively correlated with ASC colony-forming potential in vitro. ASCs were plated at a concentration of 100 cells/mL in 6 well plates
and cultured for 14 days. The number of colonies per plate divided by the cells plated x 100 was determined as the “% CFU”. a. Ungrouped BMI-ASC
colony-forming potential, and b. grouped BMI-ASC CFU potential. c. Visualization of colonies formed in 100 cm2 dishes. Values reported as N± SE; * p > 0.05.
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differentiation in vitro
To investigate the effect of BMI on ASC differentiation,
adipogenesis was induced by culturing ASCs in differenti-
ation induction medium for three days followed by culture
in maintenance medium until day 15. Differentiation was
induced in both 3% and 10% serum. Lipid formation was
assessed by percent intracytoplasmic incorporation of
Oil Red-O (ORO) into monolayers at days 7 and 15 of
adipogenesis. Oil-red-o staining at day 7 revealed a
positive correlation between BMI and adipogenesis at
early time points (as BMI increased, lipid accumulation
increased; Figure 3a). Grouping of BMI-ASCs revealed that
overweight BMI-ASCs had significantly higher Oil-Red-O
staining (61.40 ± 5.139) compared to the lean BMI-ASCs
(46.20 ± 2.70); p = 0.017 at day 7 (data not shown). Staining
at day 15 revealed that BMI has no significant effect on ASC
adipogenesis during late time points (Figure 3b). To further
investigate the correlation between BMI and adipogenesis,
nonlinear regression analyses were applied to adipogenesis
data from days 7 and 15. R2 values reflected a correlation be-
tween BMI and adipogenesis at day 7 (R2 = 0.78; Figure 3c),
and no correlation at day 15 (R2 = 0.57; Figure 3d).
Representative photomicrographs of ORO staining in
BMI-ASCs at day 15 are shown in Figure 3e.Figure 3 BMI did not significantly affect adipogenesis potential in vit
medium for three days. ASC cultures were then switched to maintenance m
incorporation of oil red-o (ORO) into monolayers cultured in adipocyte diff
micrographs of ORO staining in BMI-ASCs at day 15. d, e. Regression analys
least squares ordinary fit. R2 value reflected no significant correlation at late
(d; Day 7) R2 value reflected a correlation between BMI and adipogenic poTo determine whether cryopreservation was a factor
in the observed absence of BMI effects on adipogenic
differentiation, we induced adipogenesis in freshly iso-
lated ASCs and cryopreserved ASCs at passage 1 from
two of the same donors (mean age 49.5 ± 4.95; BMI
25.6 ± 1.56; Additional file 1: Figure S1a, b). ORO staining
(Additional file 1: Figure S1e) demonstrated no significant
difference in intracytoplasmic lipid accumulation prior to
or following the freeze-thaw process.
BMI negatively correlated with extracellular matrix
mineralization
The effects of BMI and percent FBS on ASC osteogenesis
at early and late time points was investigated by inducing
osteogenesis using an osteogenic cocktail medium for
16 days, as described in the materials and methods. Differ-
entiation was induced in both 3% and 10% serum. Calcium
deposition was assessed by Alizarin Red staining (ARS)
at days 8 and 16. ARS revealed an inverse correlation
(as BMI increased, matrix mineralization decreased)
between BMI and ASC osteogenic potential at both time
points; this was most pronounced at day 16 (Figures 4a, b).
Non linear regression analyses of the ARS data revealed
that% FBS had no significant effect on BMI-ASC osteo-
genic potential, similar to that observed with adipogenesisro. ASC adipogenesis was induced using differentiation induction
edium until day 15. Lipid formation was assessed by percent
erentiation medium for a. 7 days, and b. 15 days. c. Representative
es of differentiation data that was analyzed at days 7 and 15 using
adipogenesis timepoints (e; Day 15); however, early adipogenesis
tential. Values are reported as N ± SE; * p > 0.05, ** p > 0.001.
Figure 4 BMI significantly affected ASC early and late osteogenesis potential in vitro. ASC osteogenesis was induced using a cocktail medium for
16 days. Calcium deposition was assessed by Alizarin red staining (ARS) at a. day 8, and b. day 16. c. Representative micrographs of Alizarin Red Staining
(ARS) in BMI-ASCs at day 15. d, e. Regression analyses of differentiation data that was analyzed at days 8 and 16 using least squares ordinary fit. R2 value
reflected a strong correlation at both early and late osteogenesis time points. Values reported as N ± SE; * p > 0.05, ** p > 0.001; *** p > 0.0001.
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BMI and osteogenesis, nonlinear regression analyses were
performed on osteogenesis data from days 8 and 16 using
the least squares ordinary fit. R2 values reflected a strong
inverse correlation at both time points (day 8, R2 = 0.86;
day 16, R2 = 0.96; Figures 4c and d, respectively). Rep-
resentative photomicrographs of ARS in BMI-ASCs at
day 16 are shown in Figure 4e. To determine whether
cryopreservation was a factor in the observed effects
on osteogenic differentiation, we induced osteogenesis
in freshly isolated ASCs and cryopreserved ASCs from
two of the same donors at passage 1 (mean age 49.5 ± 4.95;
BMI 25.6 ± 1.56; Additional file 1: Figure S1c, d). ARS
(Additional file 1: Figure S1f) demonstrated no significant
difference prior to or following the freeze-thaw process.
BMI negatively correlated with alkaline phosphatase
mRNA expression
To confirm the results of Figure 4 demonstrating a sig-
nificant effect of BMI on ASC osteogenesis, alkaline
phosphatase mRNA expression was measured in add-
itional ASC cultures after induction of osteogenesis.
Alkaline phosphatase mRNA results confirmed that
when grouped, overweight BMI-ASCs were significantly
more compromised in osteogenic differentiation potential
(N ± SE: 0.71 ± 0.18) compared to the lean BMI-ASCs
(N ± SE: 4.4 ± 0.21; p = 0.017,s Figure 5a,b). Nonlinearregression analyses were performed on osteogenesis
RT-PCR data using least squares ordinary fit. The R2 value
again reflected a strong inverse correlation (R2 = 0.89) be-
tween BMI and osteogenic potential (Figure 5c).
BMI did not affect ASC relative cell size and complexity
in vitro
Recent studies indicated that mature adipocytes from
overweight and obese individuals were smaller in size
compared to adipocytes from lean individuals [27]. To de-
termine whether ASCs might exhibit similar relationships
between BMI and cell size and complexity, forward-scatter
flow cytometry (to approximate cell size), and side- scatter
flow cytometry (to approximate cell granularity, e.g.
organelles) was performed on BMI-ASCs following culture
in 2% or 10% FBS for 24 and 48 hrs. Grouping of forward
and side scatter analyses revealed no significant difference
in cell size or complexity between lean and overweight
BMI-ASCs following 24 hrs of culture in both 2% and 10%
serum (Additional file 2: Figure S2).
Discussion
The potential use of ASCs in tissue engineering and
regenerative medicine has been well demonstrated in
multiple pre-clinical animal models [24,28]. Although ASCs
have been characterized based on immunophenotype, cell
yield and differentiation properties [26,29-31], the effects of
Figure 5 Expression of alkaline phosphatase mRNA indicated that higher BMI was associated with reduced ASC osteogenesis capacity in vitro.
ASC osteogenesis was induced using a cocktail medium for 9 days. RT-PCR was performed using primers and a probe to alkaline phosphatase for a
measure of mRNA expression. ΔCT values were normalized to internal GAPDH. a. ungrouped averages of triplicates b. grouped averages of ‘lean’
(BMI <25 n = 5) and ‘overweight’ (BMI >25; n = 5) BMI-ASCs. c. Linear regression analyses of differentiation data that was analyzed at day 9 using least
squares ordinary fit. R2 value reflected a strong correlation between BMI and osteogenesis. Values reported as N ± SE; * p = 0.017.
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The present study demonstrated that cryopreserved human
ASCs from patients with higher BMIs were compromised
in colony-forming potential and growth under exposure to
low serum concentrations. Overweight BMI-ASCs were
also compromised in osteogenic differentiation capacity
when compared to lean BMI-ASCs. Cryopreservation was
not a factor in the observed differences, as both freshly
isolated BMI-ASCs and cryopreserved BMI-ASCs were
comparable in both osteogenic and adipogenic differenti-
ation capacities. Moreover, in vitro adipogenesis data sug-
gested that early time point intracytoplasmic lipid uptake
was positively correlated to BMI. Exposure of ASCs to low
serum uncovered differences among BMI-ASCs that were
less apparent at higher serum concentrations. Although
one individual donor exhibited variation in the trend of
BMI and proliferation (e.g. BMI-ASC 29.4), the determin-
ation coefficients were sufficient to form conclusions about
the correlation between proliferation and BMI.
Overweight BMI-ASC osteogenesis was reduced in-
dependent of serum levels. These results were similar
to a published report that the BMSC osteogenic alkaline
phosphatase response to mechanical strain was inversely
correlated to donor BMI [5]. These findings paralleled
clinical data demonstrating that obese patients possessed
lower relative bone area and bone mass compared to leanindividuals, when adjusted for body weight, [15], and this
may contribute to an increased risk for fractures [8].
Other clinical studies have demonstrated an inverse
correlation between body weight and bone density and
peak bone mass. In addition, there is evidence of increased
risk of implant failure following total joint knee replace-
ment in obese patients [9-11]. An understanding of the
impact of fat metabolism on bone precursors and osteo-
genic capacity will be necessary to advance ASC use in
bone repair applications.
The present data suggests that overweight BMI
dependent increase in early adipogenesis may be associated
with a decrease in osteogenic capacity. Multiple studies
suggest that when ASC fate is committed to the adipogenic
pathway, osteogenesis is concomitantly down regulated,
consistent with observations in BMSCs [25,32]. This
balance is suggested to be partly modulated by the pres-
ence and amount of glucocorticoid, the glucocorticoid
receptor pathway activity, crosstalk with the Jak/STAT3
pathway, and the subsequent activation of the AP-1
pathway [33,34]. Other studies have suggested that an
inverse relationship exists between donor age and ASC
osteogenesis [35], and that ASCs from male donors exhibit
increased osteogenic potential compared to ASCs from fe-
male donors in vitro [36]. However, conflicting outcomes
were reported in studies comparing donor age and BMSC
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an inverse correlation [37] whereas other studies reported a
positive correlation [38,39].
ASCs from overweight BMI patients (BMI >25) showed
an increase in the intracytoplasmic Oil-Red-O staining
at early adipogenesis time points, but no significant
difference at later time points. Although an increasing
trend was observed in early adipogenic potential that
correlates to BMI, an individual donor effect may have
contributed to the low adipogenesis in donor L070525
(BMI 30.65 kg/m2). Genes that are induced during both
early and late stage adipogenesis have been extensively
described [20,21,33,40-42]. Yu et. al., 2010 [42] performed
time-dependent RT-PCR analyses of genes involved in
adipogenesis in 4 donors, BMI 23.1 ± 1.4, age 39 ± 6 years.
The adipogenic transcription factor C/EBPα, the adipokines
adiponectin and leptin, and lipoprotein lipase (LPL) all
displayed a time-dependent increase during adipogenesis,
with the greatest percent increase occurring within the
initial 3-day period; however BMI had no significant
effect on the mRNA expression of the representative
genes that were upregulated on day 3 of adipogenesis
(PPARγ, Adiponectin, LPL, and aP2). This suggests that
BMI has no overall effect on adipogenesis in vitro, and
supports our data demonstrating no correlation between
BMI and late adipogenesis. However, Schipper et. al. [43]
reported age-dependent differences in ASC adipogenic
potential and proliferative capacity in vitro. Further inves-
tigation is needed relating the impact of age and BMI on
early and late ASC functionality.
It is widely accepted that hyperplasia follows adipocyte
hypertrophy in patients during fat mass expansion which
requires a gradual replenishment of the pool of adipocytes
in obese individuals [44,45]. One study proposes that
BMSCs are recruited and give rise to bone, muscle, and
both white and brown adipose tissues in response to the
appropriate developmental cues in vivo [46]. However, the
ability of ASCs to differentiate into terminally differentiated
cells of both white and brown adipose tissues adds further
complexity to the interesting dynamic. The formation
of newer, small mature adipocytes is thought to occur
via differentiation of preadipocytes; however whether
the preadipocyte originates from the fat mass, or from
the recruitment of the circulating bone-marrow progenitor
cells [47] remains to be determined. In this regard, it
should be noted that Koh et. al. [28] demonstrated that
BMSCs in bone marrow transplant mice became resi-
dent as phagocytic macrophages in adipose tissues and
resembled trans-differentiated adipocytes, but did not
express adipocyte markers.
The present study used cryopreserved ASCs that were
passaged in vitro, not freshly isolated ASCs. Several stud-
ies have investigated the cryopreservation characteristics of
ASCs and examined different methods of cryopreservationon ASC biology in vitro [41,48-50]. Thirumala et al., 2010
[22,51], showed that the post-thaw viability of ASCs
differed significantly based on the method of freezing
and rate of thaw, and determined that using an ethanol
enclosed jacketed container, with 10% DMSO and 80%
FBS in the cryopreservation medium, yielded the highest
post-thaw viability. Other studies have examined the
effects of various cryoprotective agents on cell viability,
proliferation, and osteo- and adipogenic differentiation
[47-49]. These studies indicated that proliferation and
osteo- and adipogenic differentiation of ASCs could be
maintained in vitro post-thaw. Our studies also demon-
strated that cryopreservation did not significantly affect
ASC adipogenic or osteogenic potential (Additional file 1:
Figure S1, panels a-f).
Reports on the proliferation index of freshly plated ASCs
versus cryopreserved ASCs are conflicting. James et. al.,
2011 [39] compared ASCs freshly harvested from
lipoaspirate to cryopreserved ASCs, and measured growth
using Trypan blue dye exclusion assay. Their results
demonstrated cryopreservation significantly affected
in vitro proliferative capacity. However, studies by
Deng et. al., 2008 [52], and Gonda et. al., 2008 [53] suggest
that ASC proliferative capacity following cryopreservation
is maintained. Calculations of ASC population doubling
times in our studies coincide with reports by Deng
et. al., 2008, and Gonda et. al., 2008 [52,53], as there was
no significant difference observed between the doubling
times of freshly isolated ASCs and cryopreserved ASCs
(Additional file 1: Figure S1, panel g).
James et. al., 2011 [39] also compared ASCs freshly
harvested from lipoaspirate to cryopreserved ASCs, and
measured osteogenic differentiation (alkaline phosphatase
staining and qRT-PCR), and adipogenic differentiation
(alizarin red staining and qRT-PCR). The results dem-
onstrated cryopreservation significantly affected osteo-
genic differentiation, both in vitro and in vivo. The use
of recombinant proteins such as IGF and BMP, however,
were used to mitigate the deleterious effects of the freeze–
thaw process on osteogenic potential. It should be noted
that BMI was not a tested factor, and no cytokines or sig-
naling factors were added to their differentiation medium.
A handful of cytokines and other factors are known to
stimulate osteogenic differentiation in ASCs, including
vitamin D, which was added in the differentiation medium
used in the present study. In addition, the strong determin-
ation coefficients derived from performing the nonlinear
regression analyses of the proliferation (r = 0.86-0.9) and
osteogenic differentiation studies (day 8, r = 0.86; day
16, r = 0.96) suggest donor metabolic status may also
have an effect on ASC functionality.
In vivo, near complete wound healing was observed in
mice with calvarial defects that were engrafted with fresh
human ASCs as compared to groups engrafted with
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[39]. Although freshly isolated ASCs may exhibit beneficial
properties for wound healing and other applications,
the majority of applications for ASCs will likely use
cryopreserved ASCs, therefore it is important to under-
stand the characteristics and limitations of cryopreserved
ASCs. Future studies comparing the functionality of freshly
isolated ASCs to cryopreserved ASCs within different BMI
groupings are needed to determine whether the observed
differences exist in freshly isolated cells.
Other possible contributing factors to the outcomes of
this study are patient clinical characteristics that were
unavailable from patient records, such as donor hormonal
status, smoking and other undisclosed patient parameters.
Regression analyses were conducted to determine whether
a correlation exists between age, passage and the measured
endpoints within the study. All R2 values were less than
0.2 and as such reflect no correlation between the known
factors and the measured endpoints.
Conclusions
While ASCs are proving to be promising candidates
for many applications in regenerative medicine and
tissue engineering, understanding the phenotypic char-
acteristics of these cells is essential to ensure product
consistency and suitability towards specific applications.
The present study demonstrated that in comparison
to ASCs from lean individuals, ASCs that originate
from individuals with higher BMIs had comparable
adipocyte differentiation but reduced proliferation and
osteogenic potential. Thus, ASCs derived from donors
with overweight BMI may be less than optimal for ap-




All chemicals were purchased from Sigma-Aldrich
(St. Louis, MO) or Fisher Scientific (Norcross, GA) unless
otherwise specified.
Donor demographics
All tissue was obtained from the subcutaneous abdominal
adipose tissue region of female, Caucasian patients. The
tissue was acquired from elective procedures in local plas-
tic surgery offices, with the patient’s informed consent as
approved by the Pennington Biomedical Research Center
Institution Review Board. The primary cultures were
prepared as described in Dubois et al., 2008 [54]. The
tissues used were from 11 female donors of ages between
28 and 61 with a mean ± SD of 41.5 ± 8.61 years. The
patients displayed a mean body mass index (kg/m2)
(±SD) of 26.3 ± 4.62 (summarized in Table 1).Isolation, collection, and culture of human ASCs
Both fresh and cryopreserved human ASCs were obtained
from the Pennington Biomedical Research Center using the
protocol described by Gimble et. al [21,40]. Briefly, liposuc-
tion tissues were transported to Pennington laboratory in sa-
line solution within 2 h post-surgery. The tissue was washed
at least three times with two volumes of Phosphate Buffered
Saline (PBS) to remove blood. The tissue was then digested
with one volume of PBS supplemented with 0.1% collage-
nase type I (Worthington Biochemicals, Brunswich NJ), 1%
bovine serum albumin, and 2 mM CaCl2 for 60 min at 37°C
with intermittent shaking. The floating adipocytes were
separated from the stromal-vascular fraction (SVF) by
centrifugation (300 × g) for 5 mins at room temperature.
The supernatant, containing mature adipocytes was as-
pirated and discarded and the remaining pellet was iden-
tified as the SVF. The SVF cells were suspended and plated
immediately in T225 flasks in ASC culture medium
(DMEM/F-12 Ham’s, 10% FBS [Hyclone, Logan, UT,
http://www.hyclone.com], 100 U penicillin/ 100 g strepto-
mycin/0.25 g fungizone) at a density of 0.156 ml of tissue
digest/sq cm of surface area for expansion and culture.
This initial passage of the primary cell culture was referred
to as passage 0 (P0). For cultivation of fresh ASCs for
experiments, P0 ASCs were subjected to trypsinization with
5 mL 0.25% trypsin (Life Technologies, Grand Isle, NY) for
5 minutes. Trypsin digestion was stopped by the addition
of an equal amount of ASC culture medium. P0 ASCs
were then counted using trypan blue dye exclusion, and
re-plated at the specified cell density required for each
experiment, as described.
For cryopreservation, the ASCs were resuspended in
cryopreservation medium (10% dimethylsulfoxide, 10%
Dulbecco’s modified Eagle’s medium [DMEM]/F-12 Ham’s,
80% fetal bovine serum [FBS]), frozen at 80°C in an
ethanol-jacketed closed container, and subsequently stored
in liquid nitrogen prior to thawing for individual assays.
The cells were then replated and expanded in cell factories
in the Adult Stem Cell Core at Tulane University. Patient
donor information (donor number, body mass index,
gender, and age) are shown in Table 1 and were used to
categorize ASCs as cells isolated from individuals having
either lean or overweight body mass indices (BMI-ASCs).
Following expansion, freezing and thawing, cryopreserved
P0 ASCs were counted using trypan blue dye exclusion,
directly plated and used at passage 1 for all experiments,
including the comparison between fresh and frozen cells.
Cell proliferation assays
Cell growth was measured by the MTT (3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide)
assay and CyQUANT proliferation assays. For the
CyQUANT assay, cells from each BMI were seeded in
triplicate in ASC culture medium into 24 multi-well
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of 2.5×103 cells/cm2. Following 24 and 48 hrs of culturing
in ASC culture medium supplemented with fetal bovine
serum ranges of 0% to 10%, medium was removed from
the plates, and the monolayers were rinsed with cold PBS.
Plates were then frozen at −80°C overnight. The cells were
thawed at room temperature and 200 μl of CyQUANT
GR dye/cell lysis buffer (included in the CyQUANT kit,
Invitrogen, Eugene, OR, USA) was added to each well.
The fluorescence was measured using a Fluostar Optima
microplate reader (Fluostar Optima, BMG Labtech;
Durham, NC). The excitation maximum was 485 nm,
and the emission maximum was 530 nm.
For the MTT assay, cells from each BMI were seeded
in triplicate in ASC culture medium into 24 multi-well
plates (Falcon, BD Biosciences, San Jose, CA) at a density
of 2.5×103 cells/cm2. ASC culture medium supplemented
with fetal bovine serum ranges of 0% to 10% was replaced
with fresh ASC culture medium, and 10 μl of 12 mM MTT
solution (Invitrogen, Eugene, OR, USA) was added to each
well of the 24 multi-well triplicates. The plates were incu-
bated for 4 h at 37°C. MTT formazan crystals were then
solubilized by adding 150 μ1 100% dimethylsulfoxide
(DMSO) to each well. Plates were then agitated on a plate
shaker for 5 min., following which spectrophotometric ab-
sorbance at 540 nm was immediately determined using a
scanning multi-well spectrophotometer (Fluostar Optima,
BMG Labtech; Durham, NC). At least three independent
sets of experiments were performed for each treatment.
Cell viability assessment
To quantify low serum exposure-induced apoptosis,
a well-established annexin-V/ propidium iodide (PI)
apoptosis staining was performed, and was evaluated
by flow cytometry. The control consisted of ASCs
treated in fresh ASC culture medium as previously de-
fined (cells were seeded in triplicate into 24 multi-well
plates at a density of 2.5×103 cells/cm2). Briefly, after
24 hr and 48 hr culture with 2% and 10% serum, both
floating and attached cells were pooled, harvested by
trypsinization (0.25% trypsin), washed in 10 mL of culture
medium and resuspended in 100 μL of 1× annexin-binding
buffer (included in annexin V-FITC/PI kit). Cells suspended
in a volume of 100 μL were mixed with 8 μL of annexin-
V-FITC and 8 μL of 100 μg/ mL propidium iodide (PI)
and incubated in the dark at room temperature for 15 min.
Apoptotic analyses for ASCs were performed on a
fluorescence-activated cell sorter (FACS) flow cytometer
(BD Biosciences, San Jose, CA) utilizing 488-nm laser exci-
tation and fluorescence emission at 530 nm and >575 nm.
Apoptosis was characterized by phosphatidylserine (PS)
translocation from the inner leaflet to the outer leaflet
of the lipid bilayer, while the cell membrane remains
intact. Annexin V-positive cells correspond to cells thathave experienced PS translocation. PI staining of the cells
indicates that the integrity of the cell membrane has been
compromised and is used to distinguish living and early
apoptotic cells from necrotic cells. Quadrant analysis was
performed on the fluorescence dot plot to quantify the
percentage of live, necrotic, and apoptotic cell popula-
tions, and reported in bar graph form.
Colony-formation units assay
100 ASCs in 1 ml ASC culture media were plated in
triplicates in 6 well plates (10.4 cells/cm2) and cultured
in a 37°C incubator with humidified 5% CO2. Following
14 days of culture, the media was removed, and washed
3 times with 1 mL PBS. 3.0% crystal violet (Invitrogen)
in 100% methanol was added and the plates were incubated
for 10 minutes at room temperature. The plates were then
gently flushed with dH2O for 15 min. or until the back-
ground was clear. The plates with the stained colonies were
examined under an inverted microscope and the number of
colonies that were 2 mm diameter or larger were counted
using a VersDoc Imaging system (Bio-Rad Laboratories,
Hercules, CA). The number of colonies per plate divided
by the cells plated × 100 was determined as the “% CFU”.
Adipogenic differentiation
Adipogenic differentiation of ASCs was performed over
a 12 day period as previously described [20]. Briefly,
ASCs grown in ASC culture media until the culture
reached 90-95% confluency. ASCs were then trypsinized
and plated in 24-well plates in ASC culture media at
3×104 cells/cm2 for 24 hrs to allow attachment. On day 1
(24 hours after plating), the medium was removed and cells
were incubated for three days in adipogenic differenti-
ation medium (Dulbecco’s modified Eagle’s-Ham’s F-12
medium supplemented with 3% or 10% fetal bovine
serum, 15 mM HEPES (pH 7.4), biotin (33 μM), pantothen-
ate (17 μM, Sigma), human recombinant insulin (100 nM,
Boehringer Mannheim), dexamethasone (1 μM), 1-methyl-
3-isobutylxanthine (IBMX; 0.25 mM), and rosiglitazone
(1 μM). For the remaining 9 days of the adipocyte
differentiation maintenance period, the medium was
removed every 3 days and replaced with the same
medium that did not contain IBMX and rosiglitazone
(maintenance medium).
Intracytoplasmic lipid quantification
Lipid formation was assessed by incorporation of Oil-
Red-O (ORO) (Sigma-Aldrich) into monolayers of ASCs
cultured in adipocyte differentiation medium for 12 days.
Quantitation of ORO incorporation was performed as pre-
viously described [20]. Briefly, 0.5% (w/v) oil red-o (ORO)
(Sigma-Aldrich) was prepared in ethanol. 3 parts ORO and
2 parts PBS were then mixed to make a working solution.
Monolayers of ASCs cultured in 12-well plates were rinsed
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formalin (Sigma-Aldrich) for 15 minutes. The monolayers
were then rinsed 3 times with PBS and then incubated
in ORO working solution for 45 minutes at room
temperature. Following aspiration of unincorporated ORO,
monolayers were rinsed 4 times with PBS. Stained mono-
layers were visualized with phase contrast microscopy
(Eclipse 800, Nikon; Tokyo, Japan). Incorporated ORO was
extracted by incubating stained monolayers in 100% isopro-
panol for 10 minutes. The absorbance at 510 nm of each
aliquot was then measured using a 96 well plate reader
(Fluostar Optima, BMG Labtech).
Osteogenic differentiation
Osteogenic differentiation of ASCs was performed over
a 16 day period as previously described [20]. Briefly,
ASCs cultured in ASC culture media until cells reached
90-95% confluency. ASCs were then trypsinized and
plated in 24-well plates in ASC culture media at 3×104
cells/cm2 for 24 hrs to allow attachment. On day 1
(24 hrs after replating), the medium was changed to BGJb
medium (Fitton-Jackson Modification) supplemented with
10% fetal bovine serum, 100 μg penicillin streptomycin/mL,
10 nM dexamethasone, 10 mM b-glycerolphosphate and
50 μg/mL ascorbate-2-phosphate, and 10 nM 1,25-vitamin
D3 (osteogenic medium). The cells were induced towards
osteogenesis in this medium for approximately 14 days and
the osteogenic medium was replaced every 2–3 days.
Mineralization quantification
40 mM Alizarin Red stain (ARS) (Sigma-Aldrich) was
prepared in dH2O pH 4.1. ASC monolayers cultured in the
24-well plates were rinsed 3 times with Phosphate Buffered
Solution (PBS) and fixed in 10% (v/v) buffered neutral
formalin (Sigma-Aldrich) for 15 minutes. The monolayers
were then rinsed 3 times with dH2O and incubated at room
temperature in ARS for 20 minutes with gentle shaking.
Following aspiration of unincorporated ARS, monolayers
were rinsed with dH20 4 times. Stained monolayers were
visualized with phase microscopy (Eclipse 800, Nikon;
Tokyo, Japan). Quantitation of ARS incorporation was
performed with cetylpyridinium chloride monohydrate
(CPC) (Sigma-Aldrich) extraction. Briefly, 10% (w/v) CPC
buffer was prepared in Na2P04 (pH 7.0). Stained mono-
layers were incubated in 1 ml of CPC buffer for 45 minutes.
200 μl aliquots of the extracted dye were then transferred
to 96 well plates. The absorbance at 550 nm wavelength of
each aliquot was then measured using a 96 well plate reader
(Fluostar Optima, BMG Labtech; Durham, NC).
RNA isolation and reverse transcriptase polymerase chain
reaction for alkaline phosphatase
Human ASCs were cultured under control conditions
or were induced to undergo osteogenic differentiation for9 days. Total RNA was isolated from the cells using Trizol
(Molecular Research Center, Cincinnati, OH). One-step
reverse transcriptase-polymerase chain reactions were
performed with 200 ng of total RNA using iScript One-
Step RT-PCR Kit for Probes (Bio-Rad Laboratories,
Hercules, CA). 25 μl 2x RT-PCR reaction mix containing
0.5 mM of each dNTP (dATP, dCTP, dGTP, dTTP), mag-
nesium ions, and iTaq DNA polymerase was added in a
Master Mix with 500 nM forward and reverse primers
and 250 nM probe for the amino terminal region of tis-
sue non-specific alkaline phosphatase found in liver/
bone/kidney (forward start site, 381: 5′-TCGCCTACC
AGCTCATGCATAACA-3′; reverse start site, 509: 5′-
TGAAGCTCTTCCAGGTGTCAACGA-3′; probe start
site, 450: 5′-/56-FAM/TCAGGGACATTGACGTGATCAT
GGG/3BHQ_1/3′) or GAPDH (forward start site, 117: 5′-
TCGACAGTCAGCCGCATCTTCTTT-3′; reverse start
site, 210: 5-ACCAAATCCGTTGACTCCGACCTT-S3′;
probe start site, 155: 5′-/56-FAM/AGCCACATCGCTCA
GACACCATGGG /3BHQ_1/3′). Complete reaction mix
was incubated in a real-time thermal detection system
(Bio-Rad Laboratories, Hercules, CA). cDNA synthesis
was performed using a 10 min 50°C cycle. iScript re-
verse transcriptase inactivation was performed using a
5 min 95°C cycle, and PCR cycling and detection were
performed using 15 sec 95°C, and 30 sec at 60°C. The
number of cycles performed was 40. mRNA expression
was normalized to GAPDH control and reported as
ΔΔCt values for each donor.
Statistical analysis
Statistical analysis of the data was performed using
Graphpad Prism v5.0 software; the level of P value was
set at 0.05. The Statistical analyses performed were as
follows: 2-way analysis of variances (2-way ANOVAs),
followed by Bonferroni’s post tests were used for
CyQUANT and MTT proliferation experiments, and
differentiation experiments. The Student’s one-sample
t-tests were used for colony formation and viability
experiments. Non linear regression analyses using
least fit ordinary squares were also performed on pro-
liferation, and differentiation, and the determination
coefficients (R2 values) were given to evaluate the re-
lationship between BMI and proliferation, or differen-
tiation, respectively. The coefficient of determination
is such that 0 ≤ R2 ≤ 1, and denoted the strength of
the association between BMI and proliferation, or
BMI and differentiation, where 1 represents the stron-
gest correlation. Results were reported as a positive or
inverse correlation. A positive correlation reflects an
increase in growth, differentiation potential, or size as
BMI increases. A negative correlation reflects a de-
crease in growth, differentiation potential, or size as
BMI increases.
Frazier et al. BMC Cell Biology 2013, 14:34 Page 11 of 12
http://www.biomedcentral.com/1471-2121/14/34Additional files
Additional file 1: Figure S1. Cryopreservation does not significantly
affect BMI-ASC osteogenic and adipogenic potential in vitro. BMI-ASCs
that were freshly isolated or frozen and thawed, were induced into a. b.
adipogenesis for 15 days or c. d. osteogenesis for 16 days, as described
in the materials and methods section. Oil-red-o staining was used to
evaluate adipogenic potential, and Alizarin red stain was used to
determine ECM deposition. Quantification of e. ORO and f. ARS reflected
no significant difference in adipogenic or osteogenic potential,
respectively, in freshly isolated cells compared to frozen cells. Values
reported as N ± SE.
Additional file 2: Figure S2. BMI does not significantly affect cell size
and complexity in vitro. Forward-side scatters were performed on
BMI-ASCs post low serum exposure (2% FBS supplementation), and in
ASC culture medium (10% FBS) for 24 hrs. a. Cell size (Forward scatter)
24 hrs post exposure. b. cell complexity (Side scatter) c. Representative
forward-scatter and side-scatter plots of cellular events from normal
BMI-ASCs (BMIs <25; n = 5) and overweight BMI-ASCs (BMIs >25; n = 5) in
10% serum. Values reported as N ± SE.
Abbreviations
BMI: Body mass index; ASC: Adipose tissue-derived stem cell; ORO: Oil-red-O;
ARS: Alizarin red staining; FBS: Fetal bovine serum; BMSC: Bone marrow-derived
stem cell; CFU: Colony-forming unit; FACs: Fluorescence-activated cell sorting.
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